Shohei Tsuji, Urara Kudo, Kei Takahashi, Shinsuke Nakamura, Masamitsu Shimazawa. The role of progranulin in macrophages of a glioblastoma model. Journal of Neuro-Oncology. 2024
Aika Kuriyama, Shinsuke Nakamura, Yuta Inokuchi, Hiroto Abe, Hiroto Yasuda, Yae Hidaka, Koki Nagaoka, Tetsuhiro Soeda, Masamitsu Shimazawa, Hideaki Hara. The protective effect of anti-VEGF-A/Ang-2 bispecific antibody on retinal vein occlusion model mice. European Journal of Pharmacology. 2024. 976. 176691-176691
Miruto Tanaka, Hiroto Yasuda, Shinsuke Nakamura, Masamitsu Shimazawa. H-151, a Selective STING Inhibitor, Has Potential as a Treatment for Neovascular Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 2024. 65. 8. 16-16
Shohei Tsuji, Urara Kudo, Ryo Hatakeyama, Kenji Shoda, Shinsuke Nakamura, Masamitsu Shimazawa. Linagliptin decreased the tumor progression on glioblastoma model. Biochemical and Biophysical Research Communications. 2024. 711
Aomi Muramatsu, Shinsuke Nakamura, Tasuku Hirayama, Hideko Nagasawa, Akihiro Ohira, Takashi Kitaoka, Hideaki Hara, Masamitsu Shimazawa. Both hemoglobin and hemin cause damage to retinal pigment epithelium through the iron ion accumulation. Journal of Pharmacological Sciences. 2024. 155. 2. 44-51
中村信介, 原英彰. 滲出型加齢黄斑変性における抗VEGF薬Update. Monthly Book OCULISTA(オクリスタ)『眼科医のための薬理学のイロハ』. 2022. 107. 45-52
Shinsuke Nakamura, Hideaki Hara. Prospects and Challenges of Anti-VEGF Drug Treatment for Pathological Angiogenesis of the Retina. YAKUGAKU ZASSHI. 2021. 141. 12. 1307-1317
2011/12 - Japanese Research Group for Studies of Metallothionein and Metalbioscience Executive Committee Chairman Award
Association Membership(s) (5):
日本脳サプリメント学会
, The Japanese Society of Cerebral Blood Flow and Metabolism
, Japanese Society for Ocular Pharmacology
, THE PHARMACEUTICAL SOCIETY OF JAPAN
, THE JAPANESE PHARMACOLOGICAL SOCIETY